Brain imaging to assess the effects of dopamine agonists on progression of Parkinson disease
Ahlskog, J.Eric.; Maraganore, D.M.; Uitti, R.J.; Uhl, G.R.
JAMA 288(3): 311; Author Reply 312-3
2002
ISSN/ISBN: 0098-7484 PMID: 12117385 Document Number: 541649
Document emailed within 1 workday
Related Documents
Albin, R.L.; Nichols, T.E.; Frey, K.A. 2002: Brain imaging to assess the effects of dopamine agonists on progression of Parkinson disease JAMA 288(3): 311Gekht, A.B. 2002: Use of dopamine agonists in the treatment of Parkinson's disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 102(9): 54-58
Olanow, C.Warren. 2002: The role of dopamine agonists in the treatment of early Parkinson's disease Neurology 58(4 Suppl 1): S33-S41
Löschmann, P.A.; Kunow, M.; Wachtel, H. 1992: Synergism of NBQX with dopamine agonists in the 6-OHDA rat model of Parkinson's disease Journal of Neural Transmission. Supplementum 38: 55-64
Szczudlik, A.; Rudzińska, M. 2007: Are dopamine agonists alternative therapy for levodopa in early stage of Parkinson's disease? Yes Neurologia i Neurochirurgia Polska 41(2 Suppl 1: S6-S9
Fuchs, G. 1997: Parkinson disease--problems in long-term treatment. Dopamine agonists optimize L-dopa therapy Fortschritte der Medizin 115(5): 43-45
Krivonos, O.V.; Fedorova, N.V.; Chigir', I.P. 2004: A comparative study of efficacy of dopamine receptors agonists and catechol-O-methyltransferase in the treatment of late stages of Parkinson's disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 104(1): 24-30
Stoessl, A.J.; de la Fuente-Fernández, R.úl. 2003: Dopamine receptors in Parkinson's disease: imaging studies Advances in Neurology 91: 65-71
Breese, G.R.; Baumeister, A.A.; McCown, T.J.; Emerick, S.G.; Frye, G.D.; Crotty, K.; Mueller, R.A. 1984: Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine Journal of Pharmacology and Experimental Therapeutics 231(2): 343-354
Huang, X.-M.; Sun, B.; Xue, Y.-J.; Duan, Q. 2010: Susceptibility-weighted imaging in detecting brain iron accumulation of Parkinson's disease Zhonghua Yi Xue Za Zhi 90(43): 3054-3058
Covelli, E.M.; Brunetti, A.; Di Lauro, A.; Sullo, P.; Mazzarella, G.; Tedeschi, E.; Belfiore, G. 2004: Clinical impact of correlative [123I]-FP-CIT brain imaging and neurological findings in suspect Parkinson's disease La Radiologia Medica 108(4): 417-425
Rasmussen, V.G.; Poulsen, S.H.; Dupont, E.; Østergaard, K.; Safikhany, G.; Egeblad, H. 2009: Heart abnormalities in Parkinson patients after discontinuation or continuation of ergot-derived dopamine agonists: a treatment-blinded echocardiographic study Journal of Heart Valve Disease 18(4): 463-469
Hoffmann, I.S.; Talmaciu, R.K.; Cubeddu, L.X. 1986: Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release Journal of Pharmacology and Experimental Therapeutics 238(2): 437-446
Imperato, A.; Tanda, G.; Frau, R.; Di Chiara, G. 1988: Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats Journal of Pharmacology and Experimental Therapeutics 245(1): 257-264
Brooks, D.J.; Samuel, M. 2000: The effects of surgical treatment of Parkinson's disease on brain function: PET findings Neurology 55(12 Suppl 6: S52-S59
De la Peña, C.; Fernández-Medina, J.M.; Parra-Bolaños, N.ás.; Martínez-Restrepo, Ós.A. 2016: Neuropsychological study in patients with Parkinson's disease: the effects of deep brain stimulation Revista de Neurologia 62(4): 152-156
McClelland, D.L.; Nakamoto, B.K.; Rosenkranz, R.P. 1987: Cardiovascular effects of centrally administered dopamine agonists and clonidine in the rat Proceedings of the Western Pharmacology Society 30: 243-247
Dasgupta, P.S.; Lahiri, T. 1991: Decrease in dopamine and norepinephrine concentration in different brain regions of mice during progression of Sarcoma 180 tumour Indian Journal of Experimental Biology 29(1): 86-88
Kleven, M.S.; Koek, W. 1996: Differential effects of direct and indirect dopamine agonists on eye blink rate in cynomolgus monkeys Journal of Pharmacology and Experimental Therapeutics 279(3): 1211-1219
Verma, A.; Kulkarni, S.K.; Nayar, U. 1993: Effect of D1- and D2-dopamine agonists on neocortical and hippocampal EEG activity of rat brain: modulation of rimcazole effect Methods and Findings in Experimental and Clinical Pharmacology 15(8): 515-525